Cat. #155100
Anti-FVIII [MBC 103.3]
Cat. #: 155100
Unit size: 100 ug
Availability: 10-12 weeks
Target: Factor VIII
Class: Monoclonal
Application: ELISA ; IF
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Versiti Blood Research Institute
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-FVIII [MBC 103.3]
- Alternate name: FVIII
- Research fields: Immunology
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 250
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; IF
- Description: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.
- Immunogen: FVIII
- Myeloma used: P3X63Ag8.653
- Recommended controls: IgG1
Target Details
- Target: Factor VIII
- Molecular weight: 250
- Target background: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.
Applications
- Application: ELISA ; IF
Handling
- Format: Liquid
- Concentration: 0.9-1.1mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Yarovoi et al. 2005. Blood. 105(12):4674-6. PMID: 15731176.
- Wilcox et al. 2003. J Thromb Haemost. 1(12):2477-89. PMID: 14675082.
- Rosenberg et al. 2000. Arterioscler Thromb Vasc Biol. 20(12):2689-95. PMID: 11116073.
- Rosenberg et al. 1998. J Clin Invest. 101(3):613-24. PMID: 9449695.
